Φορτώνει......
Treatment of natalizumab‐associated PML with filgrastim
OBJECTIVE: There is no consensus on the treatment of progressive multifocal leukoencephalopathy (PML) occurring in multiple sclerosis (MS) patients treated with natalizumab (Nz). We report novel immune activating treatment with filgrastim of Nz‐associated PML in MS patients treated at Rush Universit...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Ann Clin Transl Neurol |
|---|---|
| Κύριοι συγγραφείς: | , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
John Wiley and Sons Inc.
2019
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6529830/ https://ncbi.nlm.nih.gov/pubmed/31139690 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.776 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|